Liquid-based e-cigarettes emit 12 times more ultrafine dust than regular cigarettes, according to a recent study by the Korea Disease Control and Prevention Agency.
By photographing smoke and aerosols emitted from cigarettes to analyze their chemical composition, the results showed that liquid-based e-cigarettes emitted 172,845 micrograms (㎍) of ultrafine dust per 0.2 grams of liquid, 12 times more than what was emitted by non-electronic cigarettes.
Meanwhile, heated e-cigarettes emitted 3,100 ㎍ of ultrafine dust per cigarette, lower than emissions from non-electronic cigarettes.
Over a three-minute period, the ultrafine dust emitted by liquid-based e-cigarettes spread as far as 10 meters, heated e-cigarettes to between 6 and 7 meters and non-electronic cigarettes to 3 meters.
The study also revealed that black carbon, a chemical related to the automobile emissions stains, is released by all three types of cigarettes.
The highest black carbon levels were from non-electronic cigarettes, which were also present in liquid-based e-cigarettes (98.8 ㎍ per piece) and heated e-cigarettes (11.41 ㎍ per piece).
h invites itself on the King Platinum.


Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand
Samsung SDI Secures Major LFP Battery Supply Deal in the U.S.
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Russia Stocks End Flat as Energy and Retail Shares Show Mixed Performance
Gold Prices Slip Slightly in Asia as Silver Nears Record Highs on Dovish Fed Outlook
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Gulf Sovereign Funds Unite in Paramount–Skydance Bid for Warner Bros Discovery
Moore Threads Stock Slides After Risk Warning Despite 600% Surge Since IPO
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 



